Frank U. Muller

Muenster, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

A modification of retrograde Langendorff-perfusion to increase the yield of Ca2+-tolerant murine atrial cardiomyocytes isolated from remodelled, fibrotic atria.

A modification of retrograde Langendorff-perfusion to increase the yield of Ca2+-tolerant murine atrial cardiomyocytes isolated from remodelled, fibrotic atria.

Journal: Frontiers in pharmacology

Published: March 22, 2026

Cre recombinase affects calcium dynamics already in young mice.

Cre recombinase affects calcium dynamics already in young mice.

Journal: Frontiers in pharmacology

Published: January 10, 2025

Atrial Proteomic Profiling Reveals a Switch Towards Profibrotic Gene Expression Program in CREM-IbΔC-X Mice with Persistent Atrial Fibrillation.

Atrial Proteomic Profiling Reveals a Switch Towards Profibrotic Gene Expression Program in CREM-IbΔC-X Mice with Persistent Atrial Fibrillation.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2024

Atrial proteomic profiling reveals a switch towards profibrotic gene expression program in CREM-IbΔC-X mice with persistent atrial fibrillation.

Atrial proteomic profiling reveals a switch towards profibrotic gene expression program in CREM-IbΔC-X mice with persistent atrial fibrillation.

Journal: Journal of molecular and cellular cardiology

Published: December 17, 2023

An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.

An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.

Journal: Science translational medicine

Published: June 21, 2023

Hypercontractile cardiac phenotype in mice overexpressing the regulatory subunit PR72 of protein phosphatase 2A.

Hypercontractile cardiac phenotype in mice overexpressing the regulatory subunit PR72 of protein phosphatase 2A.

Journal: Frontiers in cardiovascular medicine

Published: June 13, 2023

Myocardial overexpression of protein phosphatase 2A-B56α improves resistance against ischemia-reperfusion injury.

Myocardial overexpression of protein phosphatase 2A-B56α improves resistance against ischemia-reperfusion injury.

Journal: Journal of molecular and cellular cardiology plus

Published: December 15, 2022

Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis.

Pathophysiological Mechanisms of Cardiac Dysfunction in Transgenic Mice with Viral Myocarditis.

Journal: Cells

Published: December 14, 2022

Increased in vivo perpetuation of whole-heart ventricular arrhythmia in heterozygous Na+/Ca2+ exchanger knockout mice.

Increased in vivo perpetuation of whole-heart ventricular arrhythmia in heterozygous Na+/Ca2+ exchanger knockout mice.

Journal: International journal of cardiology. Heart & vasculature

Published: December 08, 2022

Impaired myocellular Ca2+ cycling in protein phosphatase PP2A-B56α KO mice is normalized by β-adrenergic stimulation.

Impaired myocellular Ca2+ cycling in protein phosphatase PP2A-B56α KO mice is normalized by β-adrenergic stimulation.

Journal: The Journal of biological chemistry

Published: March 02, 2022

Activation of PKC results in improved contractile effects and Ca2+ cycling by inhibition of PP2A-B56α.

Activation of PKC results in improved contractile effects and Ca2+ cycling by inhibition of PP2A-B56α.

Journal: American journal of physiology. Heart and circulatory physiology

Published: February 04, 2022

Molecular determinants of health and disease.

Molecular determinants of health and disease.

Journal: Biological chemistry

Published: October 26, 2021

Showing 1-12 of 52

Last Updated: 09/26/2026